Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (DIGNITY)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Celsion
ClinicalTrials.gov Identifier:
NCT00826085
First received: January 19, 2009
Last updated: March 1, 2016
Last verified: March 2016